Jefferies Reiterates Their Hold Rating on HCP Inc


In a report released yesterday, Omotayo Okusanya from Jefferies reiterated a Hold rating on HCP Inc (NYSE: HCP), with a price target of $27. The company’s shares closed yesterday at $25.57.

According to TipRanks.com, Okusanya is a 4-star analyst with an average return of 7.5% and a 60.8% success rate. Okusanya covers the Financial sector, focusing on stocks such as Easterly Government Properties, DCT Industrial Trust Inc, and Office Properties Trust.

The word on The Street in general, suggests a Hold analyst consensus rating for HCP Inc with a $27 average price target, which is a 5.6% upside from current levels. In a report issued on July 3, BMO Capital also maintained a Hold rating on the stock with a $27 price target.

.

See today’s analyst top recommended stocks >>

The company has a one-year high of $32.34 and a one-year low of $21.48. Currently, HCP Inc has an average volume of 3.3M.

Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HCP in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HCP, Inc. is a real estate investment trust which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts